Centralized procurement drugs added to national reimbursement drug list
Number of drugs winning bids in volume-based procurement directly included into a national reimbursement drug list.
Unit Count Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Centralized procurement drugs added to national reimbursement drug list
China, as of 28 Nov 2024
Every record
All records
1 record · 1 region · 2024
| Period | Value | Source | Type |
|---|---|---|---|
| China 1 record | |||
| as of 28 Nov 2024 | 2 | NHSA · 28 Nov 2024 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 国家医疗保障局 医保动态 国家医保局 人力资源社会保障部印发2024年版国家医保药品目录 | NHSA | 28 Nov 2024 | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Centralized procurement drugs added to national reimbursement drug list. Retrieved from https://statorigin.org/indicators/centralized-procurement-drugs-added-to-national-reimbursement-drug-list